| N | YA ALL survivors | N | Siblings | P-value |
---|---|---|---|---|---|
Age, median (range) | 227 | 28 (23–41) | 70 | 28 (18–44) | 0.560 |
Gender, female, n (%) | 227 | 115 (51) | 70 | 45 (64) | 0.046 |
Marital status, n (%) | 224 | Â | 70 | Â | 0.414 |
Married or cohabitant | Â | 137 (61) | Â | 39 (56) | Â |
In a relationship | Â | 20 (9) | Â | 10 (14) | Â |
Single | Â | 67 (30) | Â | 21 (30) | Â |
Having (any) children, n (%) | 226 | 69 (31) | 70 | 24 (34) | 0.728 |
Education | 226 | Â | 70 | Â | 0.272 |
Compulsory school (9-yrs) | Â | 12 (5) | Â | 2 (3) | Â |
Upper seconday school (2–3 years) |  | 109 (48) |  | 27 (39) |  |
University < 3 yrs |  | 29 (13) |  | 9 (13) |  |
University > 3 yrs |  | 76 (34) |  | 32 (46) |  |
Occupational status, n (%) | 226 | Â | 70 | Â | 0.040 |
Student | Â | 36 (16) | Â | 17 (24) | Â |
Working | Â | 15 (70) | Â | 45 (64) | Â |
Unemployed | Â | 16 (7) | Â | 1 (1) | Â |
On sick-leave/disability pension | Â | 6 (3) | Â | 0 | Â |
On parental leave | Â | 9 (4) | Â | 6 (9) | Â |
Other | Â | 2 (1) | Â | 1 (1) | Â |
Monthly Income (€), n (%) | 223 |  | 68 |  | 0.334 |
 < 1000 |  | 61 (27) |  | 18 (27) |  |
1000–1 900 |  | 40 (18) |  | 9 (13) |  |
2000–2 900 |  | 92 (41) |  | 25 (37) |  |
3000–3 900 |  | 21 (9) |  | 12 (18) |  |
4000–4 900 |  | 7 (3) |  | 4 (6) |  |
 ≥ 5000 |  | 2 (1) |  | 0 (0) |  |
Physical training, n (%) | 226 |  | 70 |  |  < 0.001 |
Inactive | Â | 73 (32) | Â | 8 (11) | Â |
Active | Â | 100 (44) | Â | 49 (70) | Â |
Very active | Â | 53 (24) | Â | 13 (19) | Â |
BMI, n (%) | 202 | Â | 58 | Â | 0.684 |
 < 18.5 |  | 4 (2) |  | 0 |  |
19–24 |  | 114 (56) |  | 36 (62) |  |
25–29 |  | 57 (28) |  | 16 (28) |  |
30–34 |  | 18 (9) |  | 5 (9) |  |
 > 34 |  | 9 (5) |  | 1 (2) |  |
Comorbidity, n (%) | Â | Â | Â | Â | Â |
CVD | 226 | 14 (6) | 68 | 0 (0) |  < 0.05 |
Respiratory disease | 226 | 19 (8) | 69 | 8 (12) | 0.422 |
Headache/migrane | 215 | 77 (36) | 70 | 28 (40) | 0.528 |
Ulcer disease | 225 | 3 (1) | 69 | 0 (0) | 0.335 |
Diabetes | 226 | 3 (1) | 70 | 0 (0) | 0.333 |
Renal disease | 209 | 8 (4) | 70 | 2 (3) | 0.491 |
Connective tissue disease | 210 | 5 (2) | 70 | 0 (0) | 0.193 |
Cancer | 212 | 6 (3) | 69 | 1 (1) | 0.513 |
Liver disease | 215 | 2 (1) | 70 | 0 (0) | 0.418 |